Toth Financial Advisory Corp Grows Stake in Oscar Health, Inc. (NYSE:OSCR)

Toth Financial Advisory Corp grew its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 73,185.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 51,300 shares of the company’s stock after acquiring an additional 51,230 shares during the quarter. Toth Financial Advisory Corp’s holdings in Oscar Health were worth $1,088,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of OSCR. Vanguard Group Inc. raised its holdings in Oscar Health by 2.4% in the first quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock worth $216,846,000 after buying an additional 337,850 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in Oscar Health by 153.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after acquiring an additional 2,409,160 shares in the last quarter. Renaissance Technologies LLC boosted its stake in Oscar Health by 31.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock valued at $61,478,000 after purchasing an additional 934,600 shares during the last quarter. First Light Asset Management LLC raised its stake in shares of Oscar Health by 117.3% in the first quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock worth $31,265,000 after purchasing an additional 1,134,919 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its holdings in Oscar Health by 32.9% in the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock valued at $32,368,000 after acquiring an additional 507,009 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Insider Activity at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the sale, the insider now owns 76,982 shares in the company, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the transaction, the insider now directly owns 76,982 shares in the company, valued at $1,384,906.18. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Alessandrea C. Quane sold 16,793 shares of Oscar Health stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the sale, the executive vice president now directly owns 392,607 shares of the company’s stock, valued at $6,697,875.42. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 169,569 shares of company stock worth $3,007,069 in the last quarter. 25.11% of the stock is owned by company insiders.

Oscar Health Trading Down 2.6 %

Shares of Oscar Health stock traded down $0.43 during trading on Monday, hitting $15.92. The stock had a trading volume of 1,190,283 shares, compared to its average volume of 3,199,729. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. Oscar Health, Inc. has a 12 month low of $4.72 and a 12 month high of $23.79. The stock has a market cap of $3.85 billion, a PE ratio of -125.76, a PEG ratio of 34.83 and a beta of 1.62. The firm’s fifty day simple moving average is $19.00 and its 200-day simple moving average is $18.30.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The firm had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.13 billion. During the same quarter in the prior year, the firm posted ($0.07) earnings per share. The company’s quarterly revenue was up 44.6% on a year-over-year basis. As a group, sell-side analysts expect that Oscar Health, Inc. will post 0.01 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

OSCR has been the subject of several research reports. UBS Group started coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 price target for the company. Piper Sandler reiterated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research note on Tuesday, September 10th. Three equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Oscar Health has an average rating of “Moderate Buy” and a consensus price target of $24.00.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.